Companies: | 51,220 |
Products and Services: | 2,875 |
Articles and publications: | 31,146 (+2) |
Tenders & Vacancies: | 17 |
(March 24, 2022) : David Topper joined Frazier in March 2020 and brings the Life Sciences team a wealth of capital markets experience. Frazier Life sciences Acquisition Corporation now employs him as Chief Financial Officer (NASDAQ: FLAC). David is a board director at Amherst Pierpont Securities and TermGrid and a Circle Up board observer.
He was previously a member of the Portfolio Committee and an Operating Partner at General Atlantic, where he provided capital markets expertise to portfolio firms. Before joining General Atlantic, David Topper worked at J.P. Morgan as Co-Head of Equity Capital Markets. David Topper CEO oversaw the firm's extensive consulting and capital-raising operations and collaborated with the U.S. government.
Present Life of David:
Prospect Medical David Topper worked at Morgan Stanley for 22 years, where he held positions such as Co-Head of U.S.
For more information, visit https://thepublicsradio.org/article/prospect-medical-ownership-change-wins-approval-with-80m-in-escrow-and-other-conditions
###